238 related articles for article (PubMed ID: 29203124)
1. Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model.
Konstorum A; Lowengrub JS
J Theor Biol; 2018 Feb; 439():86-99. PubMed ID: 29203124
[TBL] [Abstract][Full Text] [Related]
2. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis.
Ding X; Ji J; Jiang J; Cai Q; Wang C; Shi M; Yu Y; Zhu Z; Zhang J
Cell Death Dis; 2018 Aug; 9(9):867. PubMed ID: 30158543
[TBL] [Abstract][Full Text] [Related]
3. SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
Qin H; Yang Y; Jiang B; Pan C; Chen W; Diao W; Ding M; Cao W; Zhang Z; Chen M; Gao J; Zhao X; Qiu X; Guo H
FEBS J; 2021 Sep; 288(18):5406-5429. PubMed ID: 33705609
[TBL] [Abstract][Full Text] [Related]
4. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF/c-Met Signaling Pathway.
Wang B; Liu W; Liu C; Du K; Guo Z; Zhang G; Huang Z; Lin S; Cen B; Tian Y; Yuan Y; Bu J
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):640-654. PubMed ID: 36586496
[TBL] [Abstract][Full Text] [Related]
6. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J
Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064
[TBL] [Abstract][Full Text] [Related]
7. Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.
Delitto D; Zhang D; Han S; Black BS; Knowlton AE; Vlada AC; Sarosi GA; Behrns KE; Thomas RM; Lu X; Liu C; George TJ; Hughes SJ; Wallet SM; Trevino JG
Clin Cancer Res; 2016 Apr; 22(7):1787-99. PubMed ID: 26667487
[TBL] [Abstract][Full Text] [Related]
8. The biological role of HGF-MET axis in tumor growth and development of metastasis.
Lesko E; Majka M
Front Biosci; 2008 Jan; 13():1271-80. PubMed ID: 17981628
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth.
Giannoni P; Fais F; Cutrona G; Totero D
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642077
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
11. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
12. Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.
Yamada T; Takeuchi S; Nakade J; Kita K; Nakagawa T; Nanjo S; Nakamura T; Matsumoto K; Soda M; Mano H; Uenaka T; Yano S
Clin Cancer Res; 2012 Jul; 18(13):3592-602. PubMed ID: 22553343
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
[TBL] [Abstract][Full Text] [Related]
15. HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
Hartmann S; Bhola NE; Grandis JR
Clin Cancer Res; 2016 Aug; 22(16):4005-13. PubMed ID: 27370607
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
18. Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.
Apicella M; Giannoni E; Fiore S; Ferrari KJ; Fernández-Pérez D; Isella C; Granchi C; Minutolo F; Sottile A; Comoglio PM; Medico E; Pietrantonio F; Volante M; Pasini D; Chiarugi P; Giordano S; Corso S
Cell Metab; 2018 Dec; 28(6):848-865.e6. PubMed ID: 30174307
[TBL] [Abstract][Full Text] [Related]
19. Exploring the association of POSTN
Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S
Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570
[TBL] [Abstract][Full Text] [Related]
20. Targeting HGF/c-MET Axis in Pancreatic Cancer.
Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
